Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) gapped up prior to trading on Monday . The stock had previously closed at $2.04, but opened at $2.22. Curaleaf shares last traded at $2.51, with a volume of 722,339 shares trading hands.
Wall Street Analyst Weigh In
Separately, Cormark raised shares of Curaleaf from a "hold" rating to a "moderate buy" rating in a research note on Friday.
Read Our Latest Research Report on Curaleaf
Curaleaf Trading Up 22.5%
The company has a quick ratio of 0.70, a current ratio of 1.41 and a debt-to-equity ratio of 1.08. The company has a market cap of $1.68 billion, a price-to-earnings ratio of -7.81 and a beta of 0.69. The business's fifty day simple moving average is $1.07 and its two-hundred day simple moving average is $1.05.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported ($0.06) earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.41%. On average, equities analysts predict that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.
About Curaleaf
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.